Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hong Ling
Observed names:
H Ling,
HONG LING,
Ling Hong,
Ling, Hong
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Fujian Medical University,
Shanghai Medical College of Fudan University,
Central South University,
Fudan University,
Fudan University Shanghai Cancer Center,
Shanghai Cancer Institute
show all 6
ORCID:
0000-0002-9513-3994
Observed ORCID:
0000-0002-9513-3994
OpenAlex ID:
A5012533564
The spectrum of BRCA mutations and characteristics of BRCA‐associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next‐generation sequencing
2017
·
Guan‐Tian Lang
, Jin‐Xiu Shi
, et al.
·
International Journal of Cancer
·
129
PDF
Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing
2020
·
Guan-Tian Lang
, Yi-Zhou Jiang
, et al.
·
Nature Communications
·
93
PDF
Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics
2018
·
Jin-Xiao Ren
, Yue Gong
, et al.
·
Breast Cancer Research and Treatment
·
84
PDF
Incidence and prognostic factors of patients with synchronous liver metastases upon initial diagnosis of breast cancer: a population-based study
2018
·
Hai-yun Zhao
, Yue Gong
, et al.
·
Cancer Management and Research
·
69
PDF
Incidence proportions and prognosis of breast cancer patients with bone metastases at initial diagnosis
2018
·
Yue Gong
, Jing Zhang
, et al.
·
Cancer Medicine
·
57
PDF
Influence of delayed initiation of adjuvant chemotherapy on breast cancer survival is subtype-dependent
2016
·
Ke-Da Yu
, Lei Fan
, et al.
·
Oncotarget
·
50
Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients
2015
·
Xia-Ying Kuang
, Li Chen
, et al.
·
Oncotarget
·
42
PDF
Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancer
2020
·
Bi Lian
, Yu-Chen Pei
, et al.
·
Theranostics
·
40
Patients with Nipple-Areola Paget’s Disease and Underlying Invasive Breast Carcinoma Have Very Poor Survival: A Matched Cohort Study
2013
·
Hong Ling
, Xin Hu
, et al.
·
PLoS ONE
·
39
PDF
HNRNPU promotes the progression of triple-negative breast cancer via RNA transcription and alternative splicing mechanisms
2022
·
Bo-yue Han
, Zhebin Liu
, et al.
·
Cell Death and Disease
·
36
PDF
Prognostic Value of Myeloid Differentiation Primary Response 88 and Toll-Like Receptor 4 in Breast Cancer Patients
2014
·
Fang-Jing Ma
, Zhe-Bin Liu
, et al.
·
PLoS ONE
·
35
PDF
Malignant calcification is an important unfavorable prognostic factor in primary invasive breast cancer
2012
·
Hong Ling
, Zhe‐Bin Liu
, et al.
·
Asia-Pacific Journal of Clinical Oncology
·
32
Clinical features and survival of pregnancy-associated breast cancer: a retrospective study of 203 cases in China
2020
·
Bo-yue Han
, Xiao-guang Li
, et al.
·
BMC Cancer
·
28
PDF
Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer
2020
·
Jun Chang
, Ling Hong
, et al.
·
Cancer Management and Research
·
24
PDF
An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
2023
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
·
Cancer Research
·
22
Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer
2018
·
Lin-Wei Guo
, Lin-Miao Jiang
, et al.
·
Cancer Management and Research
·
22
PDF
Fiberoptic Ductoscopy-Guided Intraductal Biopsy Improve the Diagnosis of Nipple Discharge
2009
·
Hong Ling
, Guang-yu Liu
, et al.
·
The Breast Journal
·
21
PDF
Involvement of MyoD and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene
2010
·
Wei Jin
, Yang Liu
, et al.
·
Breast Cancer Research and Treatment
·
20
Targeting SNRNP200-induced splicing dysregulation offers an immunotherapy opportunity for glycolytic triple-negative breast cancer
2024
·
Wenxiao Yang
, Luo Hong
, et al.
·
Cell Discovery
·
18
Clinical sequencing defines the somatic and germline mutation landscapes of Chinese HER2-Low Breast Cancer
2024
·
Bo-Yue Han
, Chao Chen
, et al.
·
Cancer Letters
·
15
Integrated Multi-Omics Profiling of Young Breast Cancer Patients Reveals a Correlation between Galactose Metabolism Pathway and Poor Disease-Free Survival
2023
·
XIANGCHEN HAN
, BOYUE HAN
, et al.
·
Cancers
·
11
PDF
Changing attitudes toward needle biopsies of breast cancer in Shanghai: experience and current status over the past 8 years
2015
·
Shuang Hao
, Zhe Bin Liu
, et al.
·
OncoTargets and Therapy
·
11
PDF
Clinical Characteristics and Survival Outcomes of Infiltrating Lobular Carcinoma: A Retrospective Study of 365 Cases in China
2022
·
Boyue Han
, Zhangyuan Gu
, et al.
·
Cancer Management and Research
·
10
PDF
Nomogram for Predicting Breast Cancer-Specific Mortality of Elderly Women with Breast Cancer
2020
·
Xunxi Lu
, Xiaoguang Li
, et al.
·
Medical Science Monitor
·
8
Genetic evaluation of BRCA1-A complex genes with triple-negative breast cancer susceptibility in Chinese women
2016
·
Hong Ling
, Shan Li
, et al.
·
Oncotarget
·
4
PDF
Show more works
View as search
Works count:
80
Citation count:
926
H-index:
18
I10-index:
23
Year
Topic
Type